Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BLRX | F | BioLineRx Ltd. | -4.83 | |
CLDX | D | Celldex Therapeutics, Inc. | -2.78 | |
CPIX | D | Cumberland Pharmaceuticals Inc. | -11.49 | |
CRVO | B | CervoMed Inc. | 3.18 | |
CYTK | D | Cytokinetics, Incorporated | -3.00 | |
DCPH | A | Deciphera Pharmaceuticals, Inc. | -0.04 | |
DCTH | B | Delcath Systems, Inc. | 2.70 | |
EQ | D | Equillium, Inc. | -15.00 | |
FBIO | D | Fortress Biotech, Inc. | -2.34 | |
FGEN | F | FibroGen, Inc | -4.92 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biotechnology
Biopharmaceutical
Cancer
Immune System
Blastoma
Cancer Treatment
Glioblastoma
Immunology
Monoclonal Antibody
Acute Myeloid Leukemia
Autoimmune Disease
Brain Tumor
Cancer Cell
Chemotherapy
Clinical Medicine
Drugs
Glioblastoma Multiforme
Immunotherapy
Oncology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | D | BioShares Biotechnology Products Fund | 3.17 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 3.0 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 2.9 | |
HRTS | D | Tema Cardiovascular and Metabolic ETF | 2.8 | |
XBI | D | SPDR S&P Biotech ETF | 2.62 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Medicine
Biotechnology
Biopharmaceutical
Cancer
Immune System
Blastoma
Cancer Treatment
Glioblastoma
Immunology
Monoclonal Antibody
Acute Myeloid Leukemia
Autoimmune Disease
Brain Tumor
Cancer Cell
Chemotherapy
Clinical Medicine
Drugs
Glioblastoma Multiforme
Immunotherapy
Oncology
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles